Christopher J. Nardo - 03 Jan 2023 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DRMA	Stock Option (right to buy)	Award	$0	+100,000		$0.000000	100,000	03 Jan 2023	Common Stock	100,000	$0.3100	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.